Non-Malignant Granulocyte and Monocyte Disorders: An Update

Area of Science:

• Hematology
• Immunology
• Genetics

Background:

• Non-malignant disorders of granulocytes and monocytes encompass quantitative and qualitative defects in innate immune cells.
• These conditions include neutropenias, monocytopenias, and eosinophilic syndromes, stemming from genetic mutations, autoimmune issues, or idiopathic causes.

Purpose of the Study:

• To review molecular mechanisms, genetic basis, and therapeutic innovations in non-malignant granulocyte/monocyte disorders.
• To provide a roadmap for personalized management by bridging mechanistic insights with clinical practice.

Main Methods:

• Review of current literature on molecular diagnostics, genetic mutations (ELANE, HAX1, GATA2, CSF3R), and treatment strategies.
• Integration of next-generation sequencing and quantitative flow cytometry for assessment and risk stratification.

Main Results:

• Molecular diagnostics aid in mutation detection and risk stratification for congenital neutropenias, with specific mutations like ELANE and GATA2 correlating with disease progression and susceptibility.
• Prompt, integrative assessment is advocated to differentiate benign states from early clonal hematopoiesis.

Conclusions:

• Personalized management strategies are crucial, addressing challenges in refractory neutropenia and autoimmune etiologies.
• Improved diagnostics, risk prediction, and novel biologics are needed to enhance outcomes for these underrecognized disorders.